Source comparison
TB-500 for Sports Injury: Comparison Table
Acute muscle tear (grade I–II) Promotes myoblast migration, reduces fibrosis 20–30% faster return to load tolerance vs rest alone Moderate (equine studies + human case series) Best-supported use case. Administer within 48 hours Tendon strain or partial tear Up
This comparison does not assign a generated winner or score.
- Acute muscle tear (grade I–II)
- Promotes myoblast migration, reduces fibrosis
- 20–30% faster return to load tolerance vs rest alone
- Moderate (equine studies + human case series)
- Best-supported use case. Administer within 48 hours
- Tendon strain or partial tear
- Upregulates collagen synthesis, increases vascular density
- 25–40% reduction in total healing time (equine data)
- High (multiple controlled equine trials)
- Strong veterinary evidence; human data limited to case reports
- Ligament sprain
- Enhances fibroblast migration, reduces scar tissue formation
- 15–25% faster functional recovery
- Moderate (fewer studies than tendon injuries)
- Promising but less data than tendon applications
- Chronic tendinopathy
- Stimulates angiogenesis in hypovascular tissue
- Variable. Improvement in 60–70% of cases (anecdotal)
- Low (observational reports only)
- May work for degenerative cases but timing less critical
- Bone stress fracture
- No direct osteogenic effect; supports soft-tissue healing around fracture
- Minimal. TB-500 doesn't accelerate bone mineralization
- Low (no targeted studies)
- Not a primary indication; BPC-157 may be more relevant